These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9790308)

  • 1. Malononitrilamides 715 and 279 prolong rat cardiac allograft survival, reverse ongoing rejection, inhibit allospecific antibody production and interact positively with cyclosporin.
    Qi Z; Ekberg H
    Scand J Immunol; 1998 Oct; 48(4):379-88. PubMed ID: 9790308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malononitrilamides 715 and 279 prevent accelerated cardiac allograft rejection synergistically with cyclosporin A in presensitized rats.
    Qi Z; Simanaitis M; Ekberg H
    Transpl Immunol; 1998 Jun; 6(2):94-100. PubMed ID: 9777697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malononitrilamides and tacrolimus additively prevent acute rejection in rat cardiac allografts.
    Qi Z; Simanaitis M; Ekberg H
    Transpl Immunol; 1999 Sep; 7(3):169-75. PubMed ID: 10608300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.
    Schorlemmer HU; Kurrle R
    Int J Tissue React; 1997; 19(3-4):149-56. PubMed ID: 9506316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism of the malononitrilamides 279 and 715 with cyclosporine A in the induction of long-term cardiac allograft survival.
    Lindner JK; Zantl N
    Transpl Int; 1998; 11 Suppl 1():S303-9. PubMed ID: 9665002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malononitrilamides synergistically prevent acute and treat ongoing skin allograft rejection with cyclosporine.
    Schorlemmer HU; Ruuth E; Kurrle R
    Transpl Int; 1998; 11 Suppl 1():S340-4. PubMed ID: 9665012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alloreactivity in the popliteal lymph node (PLN) assay is regulated by malononitrilamides (MNAs).
    Schorlemmer HU; Ruuth E; Kurrle R
    Int J Tissue React; 1997; 19(3-4):157-61. PubMed ID: 9506317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide controls rejection in hamster to rat cardiac xenografts.
    Xiao F; Chong AS; Foster P; Sankary H; McChesney L; Koukoulis G; Yang J; Frieders D; Williams JW
    Transplantation; 1994 Oct; 58(7):828-34. PubMed ID: 7940718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of leflunomide and cyclosporin A on rejection of cardiac allografts in the rat.
    Ostraat O; Qi ZQ; Tufveson G; Hedlund G; Ekberg H
    Scand J Immunol; 1998 Mar; 47(3):236-42. PubMed ID: 9519862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
    Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malononitrilamides reduce IgM and IgG xenoantibodies and prolong skin xenograft survival in a mouse-to rat model.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):976-9. PubMed ID: 9636394
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunomodulatory effects of a novel agent, leflunomide, in rat cardiac allotransplantation.
    D'Silva M; Candinas D; Achilleos O; Lee SJ; Dalgic A; Miki C; Mayer AD; McMaster P
    Transpl Int; 1994; 7 Suppl 1():S378-80. PubMed ID: 11271257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with a short course of LF 15-0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat-to-mouse cardiac transplantation model.
    Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
    Xenotransplantation; 2003 Jul; 10(4):325-36. PubMed ID: 12795681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts.
    Chong AS; Ma LL; Shen J; Blinder L; Yin DP; Williams JW
    Transplantation; 1997 Dec; 64(12):1650-7. PubMed ID: 9422397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression.
    Chong AS; Huang W; Liu W; Luo J; Shen J; Xu W; Ma L; Blinder L; Xiao F; Xu X; Clardy C; Foster P; Williams JA
    Transplantation; 1999 Jul; 68(1):100-9. PubMed ID: 10428276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodents.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Drugs Exp Clin Res; 1997; 23(5-6):167-73. PubMed ID: 9515226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term xenograft survival by combination therapy of malononitrilamide MNA 715 with cyclosporine.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1997 Dec; 29(8):3501-4. PubMed ID: 9414811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.